Renaissance BioScience Expands RNA Technology Patent Portfolio with Mexican Grant

Renaissance BioScience Corp. has been granted a patent by the Mexican patent office for its innovative yeast-based platform technology that enables low-cost production and effective delivery of RNA. This represents the third patent issued for the company's RNA technology following earlier grants in China and Australia, with additional jurisdictions pending. The new patent expands Renaissance's robust intellectual property portfolio of issued and pending patents for yeast-based technology across multiple end-use markets.

The company's most advanced commercial application of this RNA production and delivery system is a suite of RNAi-based biopesticide products that provide precise, targeted pest control. These products offer a strong environmental safety profile compared with broad-spectrum chemical pesticides while maintaining competitive production costs at scale. The technology integrates smoothly into current farming practices and equipment, making it accessible for agricultural implementation.

Dr. John Husnik, Renaissance's CSO and Office of the CEO, commented on the significance of the patent grant. "This patent from the Mexican office confirms the novelty and importance of our yeast-based RNA technology for producing, protecting and delivering next-generation RNA bioactive molecules," he stated. "In addition to biopesticides, this platform offers exciting opportunities across a wide range of multi-billion-dollar commercial markets."

The Mexican patent strengthens Renaissance's position in global markets where agricultural biotechnology is increasingly important. As countries seek more sustainable agricultural solutions, RNA-based technologies offer targeted approaches to pest management that reduce environmental impact. The company's technology addresses key challenges in RNA production and delivery that have limited broader adoption of RNA-based solutions across industries.

This patent milestone comes as Renaissance continues to develop its technology platform for applications beyond agriculture. The yeast-based system represents a versatile approach to RNA production that could transform multiple sectors seeking biological solutions to industrial challenges. The company's progress in securing international patents demonstrates the global relevance of its technology and positions it for commercial partnerships across different regions and markets.

The expansion of Renaissance's patent portfolio in Mexico follows similar protections in other key agricultural markets, creating a foundation for international commercialization of its RNA technology. This strategic intellectual property development supports the company's broader mission of providing cost-effective biological solutions to environmental and industrial challenges through innovative yeast engineering approaches.